The aim of this study is to evaluate the role of procalcitonin in bronchoalveolar lavage as a biomarker for assessment of severity of non-CF bronchiectasis in children in correlation with other markers (functional and radiological severity )
Children of both sex
Children aged from 6-17 years old.
Documented diagnosis of non-CF bronchiectasis by confirmed bronchiectasis findings using high-resolution computed tomographic (HRCT) lung scanning, and clinical symptoms consistent with bronchiectasis with a negative sweat test
Age less than 6 years or more than 17 years.
Children Diagnosed with cystic fibrosis bronchiectasis with confirmed positive sweat chloride test(6).
If there was a history of a recent exacerbation during the previous month preceding the study.
Children aged from 6 to 18 years diagnosed with Non-cystic fibrosis bronchiectasis
Case-control
Cross-sectional
procalcitonin
Diagnostic testlevel of procalcitonin in bronchoalveolar lavage
procalcitonin level in bronchoalveolar lavage as a biomarker for assessment of severity of non-CF bronchiectasis in children
comparison between procalcitonin level in Bronchoalveolar lavage and other markers of severity of bronchiectasis
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
